ID   KI21A_HUMAN             Reviewed;        1674 AA.
AC   Q7Z4S6; A8MX28; B0I1R9; B9EGE4; F5H0C3; F5H219; Q2UVF1; Q6UKL9; Q7Z668;
AC   Q86WZ5; Q8IVZ8; Q9C0F5; Q9NXU4; Q9Y590;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   28-JUN-2023, entry version 186.
DE   RecName: Full=Kinesin-like protein KIF21A;
DE   AltName: Full=Kinesin-like protein KIF2;
DE   AltName: Full=Renal carcinoma antigen NY-REN-62;
GN   Name=KIF21A; Synonyms=KIAA1708, KIF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS CFEOM1 THR-356;
RP   ARG-947; VAL-947; GLN-954; TRP-954 AND THR-1010.
RX   PubMed=14595441; DOI=10.1038/ng1261;
RA   Yamada K., Andrews C., Chan W.M., McKeown C.A., Magli A., De Berardinis T.,
RA   Loewenstein A., Lazar M., O'Keefe M., Letson R., London A., Ruttum M.,
RA   Matsumoto N., Saito N., Morris L., Monte M.D., Johnson R.H., Uyama E.,
RA   Houtman W.A., De Vries B., Carlow T.J., Hart B.L., Krawiecki N.,
RA   Shoffner J., Vogel M.C., Katowitz J., Goldstein S.M., Levin A.V.,
RA   Sener E.C., Ozturk B.T., Akarsu A.N., Brodsky M.C., Hanisch F., Cruse R.P.,
RA   Zubcov A.A., Robb R.M., Roggenkaemper P., Gottlob I., Kowal L., Battu R.,
RA   Traboulsi E.I., Franceschini P., Newlin A., Demer J.L., Engle E.C.;
RT   "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the
RT   extraocular muscles type 1 (CFEOM1).";
RL   Nat. Genet. 35:318-321(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Brain cortex;
RA   Pantelidou M., Lederer C.W., Zographos S.E., Pfaffl M.W., Cavallaro S.,
RA   Santama N.;
RT   "Differential expression analysis of molecular motors in ALS motor neuron
RT   disease.";
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Zan Q., Guo J.H., Yu L.;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: preparation of full-length cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-543 (ISOFORMS 1/2), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 1243-1674 (ISOFORM 4).
RC   TISSUE=Adrenal cortex, Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-597 (ISOFORM 2), AND IDENTIFICATION AS A
RP   RENAL CANCER ANTIGEN.
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-586 (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-1674 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 654-1674 (ISOFORM 3).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1212; SER-1239 AND SER-1673,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-1212; SER-1239;
RP   SER-1662; THR-1664 AND SER-1673, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1212 AND SER-1239, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-1212; SER-1225;
RP   SER-1229 AND SER-1239, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1212, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23] {ECO:0007744|PDB:5D3A}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 938-1017.
RA   Bianchi S., Kraatz S., Steinmetz M.O., Kammerer A.R.;
RT   "Structure of KIF21A regulatory coiled coil.";
RL   Submitted (AUG-2015) to the PDB data bank.
RN   [24] {ECO:0007744|PDB:5NFD}
RP   X-RAY CRYSTALLOGRAPHY (2.18 ANGSTROMS) OF 938-1017 OF MUTANT CYS-947.
RX   PubMed=30135143; DOI=10.1042/bsr20181073;
RA   Kraatz S.H.W., Bianchi S., Steinmetz M.O.;
RT   "Combinatorial use of disulfide bridges and native sulfur-SAD phasing for
RT   rapid structure determination of coiled-coils.";
RL   Biosci. Rep. 38:0-0(2018).
RN   [25] {ECO:0007744|PDB:5YBU, ECO:0007744|PDB:5YBV}
RP   X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 1146-1167 IN COMPLEX WITH KANK1
RP   AND KANK2 ANKYRIN REPEAT REGIONS, INTERACTION WITH KANK1 AND KANK2, AND
RP   MUTAGENESIS OF ARG-1154 AND LEU-1164.
RX   PubMed=29183992; DOI=10.1074/jbc.m117.817494;
RA   Guo Q., Liao S., Zhu Z., Li Y., Li F., Xu C.;
RT   "Structural basis for the recognition of kinesin family member 21A (KIF21A)
RT   by the ankyrin domains of KANK1 and KANK2 proteins.";
RL   J. Biol. Chem. 293:557-566(2018).
RN   [26] {ECO:0007744|PDB:7KLJ}
RP   X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1337-1653.
RA   Zeng H., Dong A., Loppnau P., Hutchinson A., Seitova A., Edwards A.M.,
RA   Arrowsmith C.H., Halabelian L.;
RT   "Crystal structure of the WD-repeat domain of human KIF21A.";
RL   Submitted (OCT-2020) to the PDB data bank.
RN   [27]
RP   VARIANT CFEOM1 THR-947.
RX   PubMed=16157808; DOI=10.1001/archopht.123.9.1254;
RA   Yamada K., Hunter D.G., Andrews C., Engle E.C.;
RT   "A novel KIF21A mutation in a patient with congenital fibrosis of the
RT   extraocular muscles and Marcus Gunn jaw-winking phenomenon.";
RL   Arch. Ophthalmol. 123:1254-1259(2005).
RN   [28]
RP   VARIANTS CFEOM1 THR-356; GLN-944; GLN-954; LEU-954; TRP-954 AND PRO-1008.
RX   PubMed=17511870; DOI=10.1186/1471-2156-8-26;
RA   Chan W.M., Andrews C., Dragan L., Fredrick D., Armstrong L., Lyons C.,
RA   Geraghty M.T., Hunter D.G., Yazdani A., Traboulsi E.I., Pott J.W.,
RA   Gutowski N.J., Ellard S., Young E., Hanisch F., Koc F., Schnall B.,
RA   Engle E.C.;
RT   "Three novel mutations in KIF21A highlight the importance of the third
RT   coiled-coil stalk domain in the etiology of CFEOM1.";
RL   BMC Genet. 8:26-26(2007).
RN   [29]
RP   VARIANT CFEOM1 GLU-352.
RX   PubMed=24715754;
RA   Ali Z., Xing C., Anwar D., Itani K., Weakley D., Gong X., Pascual J.M.,
RA   Mootha V.V.;
RT   "A novel de novo KIF21A mutation in a patient with congenital fibrosis of
RT   the extraocular muscles and Moebius syndrome.";
RL   Mol. Vis. 20:368-375(2014).
CC   -!- FUNCTION: Microtubule-binding motor protein probably involved in
CC       neuronal axonal transport. In vitro, has a plus-end directed motor
CC       activity. {ECO:0000250|UniProtKB:Q9QXL2}.
CC   -!- SUBUNIT: Interacts (via residues 1146-1167) with KANK1 (via ankyrin
CC       repeats 1-5) and KANK2 (via ankyrin repeats 1-5).
CC       {ECO:0000269|PubMed:29183992}.
CC   -!- INTERACTION:
CC       Q7Z4S6; Q9Y6D6: ARFGEF1; NbExp=7; IntAct=EBI-2691397, EBI-1044254;
CC       Q7Z4S6; Q14678: KANK1; NbExp=5; IntAct=EBI-2691397, EBI-2556221;
CC       Q7Z4S6; Q14678-2: KANK1; NbExp=3; IntAct=EBI-2691397, EBI-6173812;
CC       Q7Z4S6-2; Q9Y6D6: ARFGEF1; NbExp=4; IntAct=EBI-6251716, EBI-1044254;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q9QXL2}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q9QXL2}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q9QXL2}. Note=In neurons, localized to axons and
CC       dendrites. {ECO:0000250|UniProtKB:Q9QXL2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q7Z4S6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z4S6-2; Sequence=VSP_010870;
CC       Name=3;
CC         IsoId=Q7Z4S6-3; Sequence=VSP_010871;
CC       Name=4;
CC         IsoId=Q7Z4S6-4; Sequence=VSP_010872;
CC       Name=5;
CC         IsoId=Q7Z4S6-5; Sequence=VSP_010870, VSP_046791, VSP_046792;
CC       Name=6;
CC         IsoId=Q7Z4S6-6; Sequence=VSP_010870, VSP_046790, VSP_046792;
CC   -!- DISEASE: Fibrosis of extraocular muscles, congenital, 1 (CFEOM1)
CC       [MIM:135700]: A congenital ocular motility disorder marked by
CC       restrictive ophthalmoplegia affecting extraocular muscles innervated by
CC       the oculomotor and/or trochlear nerves. It is clinically characterized
CC       by anchoring of the eyes in downward gaze, ptosis, and backward tilt of
CC       the head. Patients affected by congenital fibrosis of extraocular
CC       muscles type 1 show an absence of the superior division of the
CC       oculomotor nerve (cranial nerve III) and corresponding oculomotor
CC       subnuclei. {ECO:0000269|PubMed:14595441, ECO:0000269|PubMed:16157808,
CC       ECO:0000269|PubMed:17511870, ECO:0000269|PubMed:24715754}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD42883.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH41430.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAP97680.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA90916.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY368076; AAR04774.1; -; mRNA.
DR   EMBL; AM177179; CAJ45483.1; -; mRNA.
DR   EMBL; AF450487; AAP97680.1; ALT_FRAME; mRNA.
DR   EMBL; AB290166; BAG06720.1; -; mRNA.
DR   EMBL; AC084373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC121334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF155117; AAD42883.1; ALT_SEQ; mRNA.
DR   EMBL; AK000059; BAA90916.1; ALT_SEQ; mRNA.
DR   EMBL; CH471111; EAW57803.1; -; Genomic_DNA.
DR   EMBL; BC041430; AAH41430.1; ALT_SEQ; mRNA.
DR   EMBL; BC047572; AAH47572.1; -; mRNA.
DR   EMBL; BC136414; AAI36415.1; -; mRNA.
DR   EMBL; AB051495; BAB21799.2; -; mRNA.
DR   EMBL; BX537855; CAD97863.1; -; mRNA.
DR   CCDS; CCDS31773.1; -. [Q7Z4S6-2]
DR   CCDS; CCDS53774.1; -. [Q7Z4S6-6]
DR   CCDS; CCDS53775.1; -. [Q7Z4S6-5]
DR   CCDS; CCDS53776.1; -. [Q7Z4S6-1]
DR   RefSeq; NP_001166934.1; NM_001173463.1. [Q7Z4S6-5]
DR   RefSeq; NP_001166935.1; NM_001173464.1. [Q7Z4S6-1]
DR   RefSeq; NP_001166936.1; NM_001173465.1. [Q7Z4S6-6]
DR   RefSeq; NP_060111.2; NM_017641.3. [Q7Z4S6-2]
DR   RefSeq; XP_005269064.1; XM_005269007.2.
DR   RefSeq; XP_005269070.1; XM_005269013.2. [Q7Z4S6-3]
DR   PDB; 5D3A; X-ray; 2.50 A; A/B=938-1017.
DR   PDB; 5NFD; X-ray; 2.18 A; A/B=938-1017.
DR   PDB; 5YBU; X-ray; 1.89 A; B=1146-1167.
DR   PDB; 5YBV; X-ray; 2.12 A; C/D=1146-1167.
DR   PDB; 7KLJ; X-ray; 1.52 A; A/B=1337-1653.
DR   PDBsum; 5D3A; -.
DR   PDBsum; 5NFD; -.
DR   PDBsum; 5YBU; -.
DR   PDBsum; 5YBV; -.
DR   PDBsum; 7KLJ; -.
DR   AlphaFoldDB; Q7Z4S6; -.
DR   SMR; Q7Z4S6; -.
DR   BioGRID; 120746; 96.
DR   DIP; DIP-56253N; -.
DR   IntAct; Q7Z4S6; 52.
DR   MINT; Q7Z4S6; -.
DR   STRING; 9606.ENSP00000354878; -.
DR   iPTMnet; Q7Z4S6; -.
DR   PhosphoSitePlus; Q7Z4S6; -.
DR   BioMuta; KIF21A; -.
DR   DMDM; 50400977; -.
DR   EPD; Q7Z4S6; -.
DR   jPOST; Q7Z4S6; -.
DR   MassIVE; Q7Z4S6; -.
DR   MaxQB; Q7Z4S6; -.
DR   PaxDb; Q7Z4S6; -.
DR   PeptideAtlas; Q7Z4S6; -.
DR   ProteomicsDB; 25297; -.
DR   ProteomicsDB; 25828; -.
DR   ProteomicsDB; 69226; -. [Q7Z4S6-1]
DR   ProteomicsDB; 69227; -. [Q7Z4S6-2]
DR   ProteomicsDB; 69228; -. [Q7Z4S6-3]
DR   ProteomicsDB; 69229; -. [Q7Z4S6-4]
DR   Antibodypedia; 13055; 77 antibodies from 22 providers.
DR   DNASU; 55605; -.
DR   Ensembl; ENST00000361418.10; ENSP00000354878.5; ENSG00000139116.19. [Q7Z4S6-1]
DR   Ensembl; ENST00000361961.7; ENSP00000354851.3; ENSG00000139116.19. [Q7Z4S6-2]
DR   Ensembl; ENST00000541463.6; ENSP00000438075.2; ENSG00000139116.19. [Q7Z4S6-6]
DR   Ensembl; ENST00000544797.6; ENSP00000445606.2; ENSG00000139116.19. [Q7Z4S6-5]
DR   GeneID; 55605; -.
DR   KEGG; hsa:55605; -.
DR   MANE-Select; ENST00000361418.10; ENSP00000354878.5; NM_001173464.2; NP_001166935.1.
DR   UCSC; uc001rlx.4; human. [Q7Z4S6-1]
DR   AGR; HGNC:19349; -.
DR   CTD; 55605; -.
DR   DisGeNET; 55605; -.
DR   GeneCards; KIF21A; -.
DR   GeneReviews; KIF21A; -.
DR   HGNC; HGNC:19349; KIF21A.
DR   HPA; ENSG00000139116; Tissue enhanced (brain, retina).
DR   MalaCards; KIF21A; -.
DR   MIM; 135700; phenotype.
DR   MIM; 608283; gene.
DR   neXtProt; NX_Q7Z4S6; -.
DR   OpenTargets; ENSG00000139116; -.
DR   Orphanet; 45358; Congenital fibrosis of extraocular muscles.
DR   PharmGKB; PA134882934; -.
DR   VEuPathDB; HostDB:ENSG00000139116; -.
DR   eggNOG; KOG0244; Eukaryota.
DR   GeneTree; ENSGT00940000155323; -.
DR   HOGENOM; CLU_001485_4_5_1; -.
DR   InParanoid; Q7Z4S6; -.
DR   OMA; GECTPIG; -.
DR   OrthoDB; 1131899at2759; -.
DR   PhylomeDB; Q7Z4S6; -.
DR   TreeFam; TF105224; -.
DR   PathwayCommons; Q7Z4S6; -.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SignaLink; Q7Z4S6; -.
DR   BioGRID-ORCS; 55605; 13 hits in 1153 CRISPR screens.
DR   ChiTaRS; KIF21A; human.
DR   GeneWiki; KIF21A; -.
DR   GenomeRNAi; 55605; -.
DR   Pharos; Q7Z4S6; Tbio.
DR   PRO; PR:Q7Z4S6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q7Z4S6; protein.
DR   Bgee; ENSG00000139116; Expressed in dorsal root ganglion and 193 other tissues.
DR   ExpressionAtlas; Q7Z4S6; baseline and differential.
DR   Genevisible; Q7Z4S6; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0071532; F:ankyrin repeat binding; IPI:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0003777; F:microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0007018; P:microtubule-based movement; IBA:GO_Central.
DR   CDD; cd01372; KISc_KIF4; 1.
DR   CDD; cd00890; Prefoldin; 1.
DR   CDD; cd22263; Rcc_KIF21A; 1.
DR   CDD; cd00200; WD40; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 3.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR47969; CHROMOSOME-ASSOCIATED KINESIN KIF4A-RELATED; 1.
DR   PANTHER; PTHR47969:SF15; KINESIN-LIKE PROTEIN KIN-4A; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   Pfam; PF00400; WD40; 4.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF46579; Prefoldin; 1.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoskeleton; Disease variant;
KW   Microtubule; Motor protein; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..1674
FT                   /note="Kinesin-like protein KIF21A"
FT                   /id="PRO_0000125462"
FT   DOMAIN          9..371
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   REPEAT          1345..1382
FT                   /note="WD 1"
FT   REPEAT          1385..1423
FT                   /note="WD 2"
FT   REPEAT          1449..1487
FT                   /note="WD 3"
FT   REPEAT          1490..1532
FT                   /note="WD 4"
FT   REPEAT          1541..1578
FT                   /note="WD 5"
FT   REPEAT          1582..1621
FT                   /note="WD 6"
FT   REPEAT          1624..1661
FT                   /note="WD 7"
FT   REGION          556..641
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          779..804
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          841..881
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1116..1138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1146..1167
FT                   /note="Interaction with KANK1 and KANK2"
FT                   /evidence="ECO:0000269|PubMed:29183992"
FT   REGION          1170..1318
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          365..575
FT                   /evidence="ECO:0000255"
FT   COILED          931..1019
FT                   /evidence="ECO:0000255"
FT   COILED          1053..1083
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        558..603
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        604..635
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        853..878
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1122..1138
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1194..1208
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1221..1235
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1237..1263
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1280..1305
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         88..95
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1662
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1664
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1673
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         558..570
FT                   /note="Missing (in isoform 2, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10508479,
FT                   ECO:0000303|PubMed:11214970, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2,
FT                   ECO:0000303|Ref.3, ECO:0000303|Ref.4"
FT                   /id="VSP_010870"
FT   VAR_SEQ         807..829
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_046790"
FT   VAR_SEQ         1107..1113
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046791"
FT   VAR_SEQ         1260..1319
FT                   /note="HSDSGTSEASLSPPSSPPSRPRNELNVFNRLTVSQGNTSVQQDKSDESDSSL
FT                   SEVHRSSR -> QSDESDSSLSEVH (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_010871"
FT   VAR_SEQ         1304..1320
FT                   /note="Missing (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_046792"
FT   VAR_SEQ         1315
FT                   /note="H -> HS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010872"
FT   VARIANT         352
FT                   /note="D -> E (in CFEOM1; de novo mutation)"
FT                   /evidence="ECO:0000269|PubMed:24715754"
FT                   /id="VAR_074031"
FT   VARIANT         356
FT                   /note="M -> T (in CFEOM1; dbSNP:rs121912588)"
FT                   /evidence="ECO:0000269|PubMed:14595441,
FT                   ECO:0000269|PubMed:17511870"
FT                   /id="VAR_019399"
FT   VARIANT         944
FT                   /note="E -> Q (in CFEOM1)"
FT                   /evidence="ECO:0000269|PubMed:17511870"
FT                   /id="VAR_074032"
FT   VARIANT         947
FT                   /note="M -> R (in CFEOM1; dbSNP:rs121912590)"
FT                   /evidence="ECO:0000269|PubMed:14595441"
FT                   /id="VAR_019400"
FT   VARIANT         947
FT                   /note="M -> T (in CFEOM1)"
FT                   /evidence="ECO:0000269|PubMed:16157808"
FT                   /id="VAR_027021"
FT   VARIANT         947
FT                   /note="M -> V (in CFEOM1; dbSNP:rs121912589)"
FT                   /evidence="ECO:0000269|PubMed:14595441"
FT                   /id="VAR_019401"
FT   VARIANT         954
FT                   /note="R -> L (in CFEOM1)"
FT                   /evidence="ECO:0000269|PubMed:17511870"
FT                   /id="VAR_074033"
FT   VARIANT         954
FT                   /note="R -> Q (in CFEOM1; dbSNP:rs121912586)"
FT                   /evidence="ECO:0000269|PubMed:14595441,
FT                   ECO:0000269|PubMed:17511870"
FT                   /id="VAR_019402"
FT   VARIANT         954
FT                   /note="R -> W (in CFEOM1; dbSNP:rs121912585)"
FT                   /evidence="ECO:0000269|PubMed:14595441,
FT                   ECO:0000269|PubMed:17511870"
FT                   /id="VAR_019403"
FT   VARIANT         1008
FT                   /note="A -> P (in CFEOM1)"
FT                   /evidence="ECO:0000269|PubMed:17511870"
FT                   /id="VAR_074034"
FT   VARIANT         1010
FT                   /note="I -> T (in CFEOM1; dbSNP:rs121912587)"
FT                   /evidence="ECO:0000269|PubMed:14595441"
FT                   /id="VAR_019404"
FT   MUTAGEN         1154
FT                   /note="R->A: Very weak binding affinity for KANK1 and
FT                   KANK2."
FT                   /evidence="ECO:0000269|PubMed:29183992"
FT   MUTAGEN         1164
FT                   /note="L->A: Does not bind to KANK1 or KANK2."
FT                   /evidence="ECO:0000269|PubMed:29183992"
FT   CONFLICT        172
FT                   /note="K -> R (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="R -> G (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="A -> G (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        315
FT                   /note="S -> C (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        596..597
FT                   /note="NN -> TQ (in Ref. 3; AAP97680 and 8; AAD42883)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        653
FT                   /note="E -> D (in Ref. 3; AAP97680)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        801..802
FT                   /note="DQ -> AP (in Ref. 3; AAP97680)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        801
FT                   /note="D -> G (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        813
FT                   /note="E -> G (in Ref. 3; AAP97680)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        826
FT                   /note="K -> Q (in Ref. 3; AAP97680)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        875
FT                   /note="R -> G (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        892
FT                   /note="L -> S (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1071
FT                   /note="Q -> R (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1167
FT                   /note="D -> G (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1237
FT                   /note="E -> D (in Ref. 7; AAI36415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1341
FT                   /note="H -> N (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1378..1379
FT                   /note="QE -> HR (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1429
FT                   /note="G -> A (in Ref. 2; CAJ45483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1503
FT                   /note="I -> T (in Ref. 11; CAD97863)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1511
FT                   /note="I -> T (in Ref. 11; CAD97863)"
FT                   /evidence="ECO:0000305"
FT   HELIX           939..973
FT                   /evidence="ECO:0007829|PDB:5NFD"
FT   HELIX           982..1014
FT                   /evidence="ECO:0007829|PDB:5NFD"
FT   HELIX           1153..1155
FT                   /evidence="ECO:0007829|PDB:5YBU"
FT   HELIX           1160..1164
FT                   /evidence="ECO:0007829|PDB:5YBU"
FT   STRAND          1338..1344
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1350..1355
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1357..1364
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1369..1373
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   TURN            1374..1376
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1379..1383
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1392..1396
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   TURN            1397..1400
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1401..1406
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1409..1414
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1416..1418
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1420..1426
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1431..1434
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1454..1459
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1463..1470
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1473..1478
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   TURN            1479..1482
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1483..1488
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1495..1504
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1507..1514
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1519..1525
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1530..1532
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1535..1537
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1546..1552
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1555..1560
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1565..1569
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   TURN            1570..1573
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1574..1579
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1582..1585
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1587..1592
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1596..1603
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1606..1612
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   TURN            1613..1615
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1618..1623
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1629..1634
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1639..1643
FT                   /evidence="ECO:0007829|PDB:7KLJ"
FT   STRAND          1646..1652
FT                   /evidence="ECO:0007829|PDB:7KLJ"
SQ   SEQUENCE   1674 AA;  187179 MW;  292AFA5F2C0C6F9A CRC64;
     MLGAPDESSV RVAVRIRPQL AKEKIEGCHI CTSVTPGEPQ VFLGKDKAFT FDYVFDIDSQ
     QEQIYIQCIE KLIEGCFEGY NATVFAYGQT GAGKTYTMGT GFDVNIVEEE LGIISRAVKH
     LFKSIEEKKH IAIKNGLPAP DFKVNAQFLE LYNEEVLDLF DTTRDIDAKS KKSNIRIHED
     STGGIYTVGV TTRTVNTESE MMQCLKLGAL SRTTASTQMN VQSSRSHAIF TIHVCQTRVC
     PQIDADNATD NKIISESAQM NEFETLTAKF HFVDLAGSER LKRTGATGER AKEGISINCG
     LLALGNVISA LGDKSKRATH VPYRDSKLTR LLQDSLGGNS QTIMIACVSP SDRDFMETLN
     TLKYANRARN IKNKVMVNQD RASQQINALR SEITRLQMEL MEYKTGKRII DEEGVESIND
     MFHENAMLQT ENNNLRVRIK AMQETVDALR SRITQLVSDQ ANHVLARAGE GNEEISNMIH
     SYIKEIEDLR AKLLESEAVN ENLRKNLTRA TARAPYFSGS STFSPTILSS DKETIEIIDL
     AKKDLEKLKR KEKRKKKRLQ KLEESNREER SVAGKEDNTD TDQEKKEEKG VSERENNELE
     VEESQEVSDH EDEEEEEEEE EDDIDGGESS DESDSESDEK ANYQADLANI TCEIAIKQKL
     IDELENSQKR LQTLKKQYEE KLMMLQHKIR DTQLERDQVL QNLGSVESYS EEKAKKVRSE
     YEKKLQAMNK ELQRLQAAQK EHARLLKNQS QYEKQLKKLQ QDVMEMKKTK VRLMKQMKEE
     QEKARLTESR RNREIAQLKK DQRKRDHQLR LLEAQKRNQE VVLRRKTEEV TALRRQVRPM
     SDKVAGKVTR KLSSSDAPAQ DTGSSAAAVE TDASRTGAQQ KMRIPVARVQ ALPTPATNGN
     RKKYQRKGLT GRVFISKTAR MKWQLLERRV TDIIMQKMTI SNMEADMNRL LKQREELTKR
     REKLSKRREK IVKENGEGDK NVANINEEME SLTANIDYIN DSISDCQANI MQMEEAKEEG
     ETLDVTAVIN ACTLTEARYL LDHFLSMGIN KGLQAAQKEA QIKVLEGRLK QTEITSATQN
     QLLFHMLKEK AELNPELDAL LGHALQDLDS VPLENVEDST DEDAPLNSPG SEGSTLSSDL
     MKLCGEVKPK NKARRRTTTQ MELLYADSSE LASDTSTGDA SLPGPLTPVA EGQEIGMNTE
     TSGTSAREKE LSPPPGLPSK IGSISRQSSL SEKKIPEPSP VTRRKAYEKA EKSKAKEQKH
     SDSGTSEASL SPPSSPPSRP RNELNVFNRL TVSQGNTSVQ QDKSDESDSS LSEVHRSSRR
     GIINPFPASK GIRAFPLQCI HIAEGHTKAV LCVDSTDDLL FTGSKDRTCK VWNLVTGQEI
     MSLGGHPNNV VSVKYCNYTS LVFTVSTSYI KVWDIRDSAK CIRTLTSSGQ VTLGDACSAS
     TSRTVAIPSG ENQINQIALN PTGTFLYAAS GNAVRMWDLK RFQSTGKLTG HLGPVMCLTV
     DQISSGQDLI ITGSKDHYIK MFDVTEGALG TVSPTHNFEP PHYDGIEALT IQGDNLFSGS
     RDNGIKKWDL TQKDLLQQVP NAHKDWVCAL GVVPDHPVLL SGCRGGILKV WNMDTFMPVG
     EMKGHDSPIN AICVNSTHIF TAADDRTVRI WKARNLQDGQ ISDTGDLGED IASN
//
